Home › Major Depressive Disorder › Connecticut › New Haven
Major Depressive Disorder clinical trials in New Haven, CT
6 studies for Major Depressive Disorder are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RecruitingPhase 3
- Yale School of Medicine - Yale Program for Psychedelic Science, New Haven
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
RecruitingPhase 3
- Yale University School of Medicine, New Haven
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 3
- Neurocrine Clinical Site, New Haven
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
RecruitingPhase 2
- VA Connecticut Healthcare System, West Haven · 3 mi away
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
RecruitingPhase 1
- Yale University, New Haven
Imaging Depression in Parkinson's Disease
RecruitingPhase 2Healthy volunteers welcome
- Yale University, New Haven
Major Depressive Disorder trials in other cities
- New York City, NY37 studies
- Boston, MA31 studies
- Atlanta, GA25 studies
- Philadelphia, PA23 studies
- Orlando, FL19 studies
- Miami, FL18 studies
- Chicago, IL17 studies
- Tampa, FL17 studies
- Houston, TX16 studies
- San Diego, CA16 studies
- Little Rock, AR14 studies
- Orange, CA13 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Opioid Overdose18 studies
- Alcohol Use Disorder (AUD)17 studies
- Acute Myeloid Leukemia17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.